1921
Volume 2, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Summary

Eighty-two Hondurans were treated for malaria with 7-chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino] quinoline diphosphate (Plaquenil). Sixty-eight of them (21 with , 47 with ) were given a single oral dose of 1.25 gm. Fourteen others with infections were given an intravenous dose of 0.36 gm. in 500 cc. of normal saline solution. Both the immediate and the late results were encouraging. Toxic side-effects of the drug were not encountered. Plaquenil, therefore, warrants further investigation; its experimental use will be continued in this and other locations.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1953.2.805
1953-09-01
2017-09-25
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1953.2.805
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error